According to Circular 1 of 2013 – consolidated FDI Policy, relating to FDI in Pharmaceuticals Sector, 100% FDI is allowed for green field and Brownfield projects under automatic route and the government approval route respectively. However, on 08.01.2014, vide press note 1 of 2014 series Government of India reviewed the position and decided that the existing policy would continue with the condition that 'non-compete' clause would not be allowed except in special circumstances with the approval of FIPB.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.